-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JHmB8VgCnWblAGpOg6wkHhyEg4ZFTJG5dThJgO8QXHRC5z39+I1dgVsAywK75D/F 3PKyct0+3zAZgwKuK84rtw== 0001144204-07-005865.txt : 20070326 0001144204-07-005865.hdr.sgml : 20070326 20070208140917 ACCESSION NUMBER: 0001144204-07-005865 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TARGETED GENETICS CORP /WA/ CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2066237612 MAIL ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 CORRESP 1 filename1.htm
[Letterhead of Targeted Genetics Corporation]

 

February 8, 2007

VIA FACSIMILE (202-772-9217) AND EDGAR

Mr. Jeffrey P. Riedler
Assistant Director
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention: Song P. Brandon, Esq.

Re:
Targeted Genetics Corporation - Request for Acceleration of
Effectiveness of Registration Statement on Form S-3, Commission File
No. 333-140187

Dear Mr. Riedler,

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Targeted Genetics Corporation (the “Company”) hereby requests that the effective date of its Registration Statement on Form S-3, Registration No. 333-140187 (the “Registration Statement”) be accelerated so that the Registration Statement may become effective at the later of: (a) 4:00 p.m., Eastern Standard Time, Thursday, February 8, 2007, or as soon as practicable thereafter; and (b) such later time as the Company may request by telephone to the Commission. The Company hereby authorizes Stephen M. Graham or Lewis S. Malakoff of Orrick, Herrington & Sutcliffe LLP, counsel for the Company, to make such a request on its behalf.
 
     
 
Very truly yours,
 
TARGETED GENETICS CORPORATION
 
 		  
 		  
 
  /s/ David J. Poston
   
 
David J. Poston
Vice President Finance and
Chief Financial Officer


cc:       Orrick, Herrington & Sutcliffe LLP
 
 
 -----END PRIVACY-ENHANCED MESSAGE-----